Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.54 |
| ▸ | FAAH | O00519 | 3/20 | 0.47 |
| ▸ | SOAT1 | P35610 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.43 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.43 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | CES2 | O00748 | 3/20 | 0.42 |
| ▸ | CES1 | P23141 | 3/20 | 0.42 |
| ▸ | PPARG | P37231 | 6/20 | 0.41 |
| ▸ | PPARD | Q03181 | 6/20 | 0.41 |
| ▸ | PPARA | Q07869 | 6/20 | 0.41 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.41 |
| ▸ | TSHR | P16473 | 4/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4619163 | 1.00 | MEN1 (0.54) | MEN1KMT2AFAAHSOAT1TP53 | |
| SCHEMBL6549736 | 1.00 | MEN1 (0.54) | MEN1KMT2AFAAHSOAT1TP53 | |
| SCHEMBL1820400 | 1.00 | MEN1 (0.54) | MEN1KMT2AFAAHSOAT1TP53 | |
| SCHEMBL4671252 | 1.00 | MEN1 (0.54) | MEN1KMT2AFAAHSOAT1TP53 | |
| SCHEMBL81151 | 1.00 | MEN1 (0.54) | MEN1KMT2AFAAHSOAT1TP53 | |
| SCHEMBL76612 | 1.00 | MEN1 (0.54) | MEN1KMT2AFAAHSOAT1TP53 | |
| SCHEMBL80554 | 1.00 | MEN1 (0.54) | MEN1KMT2AFAAHSOAT1TP53 | |
| SCHEMBL1268125 | 0.98 | — | — | |
| SCHEMBL1238478 | 0.90 | — | — | |
| SCHEMBL5047549 | 0.90 | FAAH (0.63) | MEN1KMT2AFAAHSOAT1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3836971-A1 | CONJUGATES AND METHODS OF USING THE SAME | Flagship Pioneering Innovations V, Inc. (US) | 2021-06-23 | — | — | EP | claimed |
| US-20210162057-A1 | CONJUGATES AND METHODS OF USING THE SAME | FLAGSHIP PIONEERING INNOVATIONS V, INC. | 2021-06-03 | — | — | US | claimed |
| WO-2020037009-A1 | CONJUGATES AND METHODS OF USING THE SAME | FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) | 2020-02-20 | — | — | WO | claimed |
| US-11998610-B2 | Conjugates and methods of using the same | FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) | 2024-06-04 | — | — | US | disclosed |
| US-20230157996-A1 | SMALL-MOLECULE INHIBITOR TARGETING EB VIRUS NUCLEAR ANTIGEN PROTEIN, PREPARATION METHOD AND USE THEREOF | Shenzhen Bay Laboratory (CN) | 2023-05-25 | — | — | US | disclosed |
| EP-4151621-A1 | SMALL-MOLECULE INHIBITOR TARGETING EB VIRUS NUCLEAR ANTIGEN PROTEIN, PREPARATION METHOD THEREFOR AND USE THEREOF | Shenzhen Bay Laboratory (CN) | 2023-03-22 | — | — | EP | disclosed |
| CN-113754541-A | Micromolecule inhibitor targeting EB virus nuclear antigen protein, preparation method and application thereof | 深圳湾实验室 | 2021-12-07 | — | — | CN | disclosed |
| EP-3836971-A1 | CONJUGATES AND METHODS OF USING THE SAME | Flagship Pioneering Innovations V, Inc. (US) | 2021-06-23 | — | — | EP | disclosed |
| US-20210162057-A1 | CONJUGATES AND METHODS OF USING THE SAME | FLAGSHIP PIONEERING INNOVATIONS V, INC. | 2021-06-03 | — | — | US | disclosed |
| WO-2020037009-A1 | CONJUGATES AND METHODS OF USING THE SAME | FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) | 2020-02-20 | — | — | WO | disclosed |
| US-7301029-B2 | Bipyridine Derivatives | FUJIFILM FINECHEMICALS CO., LTD. (JP) | 2007-11-27 | — | — | US | disclosed |
| EP-0752615-A2 | Method for hardening gelatin and silver halide photographic light sensitive materials employing the method | KONICA CORPORATION (JP) | 1997-01-08 | — | — | EP | disclosed |
| US-5571660-A | Method for forming an image | KONICA CORPORATION (JP) | 1996-11-05 | — | — | US | disclosed |
| EP-0642055-A1 | A method of forming an image | KONICA CORPORATION (JP) | 1995-03-08 | — | — | EP | disclosed |
| US-5279920-A | Containing a hydrazide compound | KONICA CORPORATION (JP) | 1994-01-18 | — | — | US | disclosed |
| EP-0539925-A1 | Silver halide photographic light sensitive material | KONICA CORPORATION (JP) | 1993-05-05 | — | — | EP | disclosed |
| US-4897469-A | Aniline series azo reactive dyes ortho- or para-substituted by vinyl sulfonyl reactive groups | BASF AKTIENGESELLSCHAFT (DE) | 1990-01-30 | — | — | US | disclosed |
| US-4873172-A | STABLE DEVELOPER CONTAINING A HYDRAZINE DERIVATIVE AND A COMPOUND BASED ON A FJUSED 4H-1,2,4-TRIAZOLE RING | FUJI PHOTO FILM CO., LTD. (JP) | 1989-10-10 | — | — | US | disclosed |
| US-4738918-A | IN PRESENCE OF COMPOUND CONTAINING 1,2,4-TRIAZOLE RING | FUJI PHOTO FILM CO., LTD. (JP) | 1988-04-19 | — | — | US | disclosed |
| US-4275148-A | THIO SUBSTITUTED PYRAZOLINES AS MAGENTA COUPLERS | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1981-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230157996-A1 | SMALL-MOLECULE INHIBITOR TARGETING EB VIRUS NUCLEAR ANTIGEN PROTEIN, PREPARATION METHOD AND USE THEREOF | SSB, EBNA1BP2, PML | MEN1 763/4885KMT2A 854/4885FAAH 2966/4885 |
| US-11998610-B2 | Conjugates and methods of using the same | CD47, CD44, CD74 | MEN1 2346/4885KMT2A 3520/4885FAAH 2742/4885 |
| US-20210162057-A1 | CONJUGATES AND METHODS OF USING THE SAME | CD47, CD44, CD74 | MEN1 2346/4885KMT2A 3520/4885FAAH 2742/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.